Insomnia During Pregnancy and After Birth
Pregnancy and the months after birth can bring frequent waking, discomfort, changing schedules, and a newborn's needs. Those realities can coexist with insomnia that deserves its own assessment. Early trials of behavioral sleep treatment are encouraging, but they studied specific groups and follow-up periods—not every pregnant or postpartum person, and not every outcome families care about.
What the evidence supports
- CBT-I has been studied for insomnia during pregnancy, with some randomized trials following participants into postpartum.
- One trial among women with diagnosed insomnia during pregnancy reported later postpartum differences in insomnia severity and some diary-based wakefulness measures.
- A separate three-arm study in first-time pregnant participants with elevated insomnia symptoms found lower average postpartum insomnia scores in its CBT-I group than in a sleep-hygiene control.
What remains uncertain
- These results do not establish effects for all pregnancies, birth experiences, family structures, or postpartum health conditions.
- Trials do not show that CBT-I prevents postpartum depression, replaces mental-health treatment, or changes infant sleep in a reliable way.
- Longer-term effectiveness, practical access, and the best adaptation for caregiving-related sleep disruption need further study.
Evidence last reviewed: October 6, 2026. Conclusions may change as new research is published.
Disrupted sleep and insomnia can overlap
Sleep changes are common across pregnancy and after birth, but “common” does not mean every difficulty is the same. Physical discomfort, reflux, frequent urination, fetal movement, feeding, and infant waking may interrupt sleep opportunity. Insomnia involves difficulty sleeping and distress or daytime effects even when there is a reasonable chance to sleep. A person may have both: unavoidable caregiving interruptions and trouble falling back asleep, for example.
The distinction is not a test of willpower. It helps a clinician understand what can be changed, what is part of the current context, and whether another medical or mental-health concern deserves attention. A short sleep diary can document when opportunities to sleep occur, what interrupts them, how long it takes to return to sleep, and how the person is functioning. This page focuses on insomnia assessment and treatment; it does not set infant feeding or sleep practices.
- 🤰 During pregnancy: ask about sleep-onset or maintenance problems, discomfort, schedule, mood, medications, and symptoms that may point to another sleep or medical condition.
- 🍼 After birth: separate time awake because an infant needs care from time awake when the opportunity to sleep has returned but sleep remains difficult.
- 🫶 At any stage: distress and impaired daytime functioning matter even when sleep is interrupted for understandable reasons.
What perinatal CBT-I trials tell us
The strongest direct evidence is still a small set of clinical trials. They differ in whether participants had an insomnia diagnosis or elevated symptoms, the timing and amount of therapy, who provided it, the comparator, and the follow-up. These design differences matter when deciding what a finding can support.
| Trial group | Intervention and comparison | What the finding can—and cannot—say |
|---|---|---|
| 🤰 Pregnancy CBT-I trial | 194 women were randomized; the original analysis included 179 with baseline data. A later report assessed outcomes through 30 weeks postpartum. | Some insomnia and reported wakefulness outcomes favored CBT-I at later postpartum points; actigraphy and diary measures did not show a group difference in postpartum total awake time. |
| 👶 127-person trial | First-time pregnant participants with ISI scores of at least 8 were assigned to therapist-assisted CBT-I, a responsive bassinet, or sleep-hygiene control. | Average insomnia-severity scores across postpartum assessments were lower in the CBT-I group than control; the bassinet did not show the same result on that primary outcome. |
| 📍 Shared boundary | Each trial used defined eligibility rules, a particular intervention, and its own comparison group. | These results do not apply automatically to all perinatal patients or establish effects on every parent, infant, or mental-health outcome. |
Read the pregnancy-to-postpartum trial closely
The original pregnancy trial randomized 194 women with insomnia disorder to CBT-I or an active control; its analysis included 179 participants with baseline data. A later postpartum report assessed outcomes at 8, 18, and 30 weeks after birth and included women who provided data for at least one postpartum assessment (68 in CBT-I, 61 in control). At the later assessment, the group difference in insomnia severity reached statistical significance; the authors also reported more time awake, excluding infant-care time, in the control group at postpartum assessments. They did not find a group difference in actigraphy-measured total awake time or the two diary measures of time awake (Manber et al., Obstetrics & Gynecology, 2019; Manber et al., Journal of Clinical Sleep Medicine, 2023).
Those findings are useful but do not establish that CBT-I improves postpartum sleep for everyone. The report analyzed participants who provided at least one postpartum assessment, and treatment response during pregnancy related to later symptom patterns. Infant-related waking remained a separate factor: time spent awake caring for the infant did not differ between groups. The study supports offering clinical attention to insomnia during pregnancy; it does not show that behavioral treatment removes the ordinary demands of caring for a newborn.
A different trial looked at preventing postpartum insomnia
A separate randomized study enrolled 127 nulliparous participants at 26–32 weeks of pregnancy who had Insomnia Severity Index scores of at least 8. Participants were assigned to therapist-assisted CBT-I delivered during pregnancy and postpartum, a responsive bassinet intervention intended to support infant sleep, or a sleep-hygiene booklet. The primary outcome was average ISI score across 2, 6, and 12 months postpartum. Compared with the sleep-hygiene control, average scores were lower in the CBT-I group (effect size 0.56; p=.014); the bassinet group did not differ significantly on that outcome (Quin et al., Sleep, 2024).
This is evidence about one study's selected population and primary symptom outcome. Participants were first-time mothers with elevated symptoms, not a representative sample of every family or a trial of all infant sleep supports. The result does not establish that CBT-I prevents postpartum depression, improves infant outcomes, or can replace individualized obstetric, pediatric, or mental-health care. Those are separate outcomes and require evidence designed to test them. An average symptom score across follow-ups does not describe every participant's individual response. The result also cannot settle a decision for any individual patient.
Adapting behavioral treatment to a changing night
Standard CBT-I methods can be adapted when the sleep opportunity changes from week to week or is interrupted by infant care. A clinician may use flexible sleep and wake windows, focus on the time that is realistically available, and treat distress around sleep without framing unavoidable caregiving as a bad habit. The plan should fit the person's actual household, recovery, and responsibilities rather than an idealized schedule.
- 📝 Track the opportunity as well as sleep: note infant-care interruptions separately from periods when sleep was possible but did not come.
- 🧑⚕️ Discuss safety before changing a sleep window: pregnancy, postpartum recovery, daytime sleepiness, mood conditions, and caregiving demands may affect the plan.
- 🤝 Coordinate when care overlaps: an obstetric clinician, primary-care clinician, behavioral sleep provider, and mental-health professional may each have relevant information.
⚠️ Medication decisions are individualized
Pregnancy, breastfeeding, postpartum recovery, and other medicines can change a medication's risk-benefit discussion. Do not start, stop, or change a prescription or supplement based on this page. The FDA boxed warning for complex sleep behaviors concerns eszopiclone, zaleplon, and zolpidem specifically; it is not a warning shared by every insomnia medicine. Discuss the exact product and situation with a qualified clinician.
When to ask for more support
Bring persistent sleep difficulty, significant distress, or trouble functioning to a clinician rather than waiting for the postpartum period to end. Mention symptoms that could reflect another sleep or health problem, as well as any medication or supplement use. A sleep diary is one possible aid, but it does not diagnose insomnia; clinical context remains essential.
Sleep concerns and mental health can overlap without one serving as proof of the other. If mood symptoms feel severe, are worsening, or include thoughts of self-harm or inability to stay safe, seek urgent help from local emergency or crisis services and a clinician. That is a mental-health safety concern, not a sleep-habit problem. For the general CBT-I components and formats, see CBT-I: What Treatment Actually Involves; for the everyday assessment tools, see Sleep Diaries, Trackers, and Insomnia Assessment.
Questions, answered briefly
- ❓ “Is every postpartum awakening insomnia?” No. Infant care can interrupt sleep opportunity; persistent difficulty sleeping when there is a chance to sleep, distress, and daytime effects are worth discussing in context.
- 📊 “Does one trial mean CBT-I works for everyone in pregnancy?” No. Trials support further clinical use and study, but each enrolled selected participants and measured specific outcomes over bounded periods.
- 🧭 “Should I change my schedule or medication now?” Ask a clinician familiar with pregnancy or postpartum care and insomnia treatment. This page cannot individualize sleep windows, drug risks, or feeding-related decisions.
The Bottom Line
- Perinatal sleep disruption and insomnia can overlap. A good assessment distinguishes limited sleep opportunity from difficulty sleeping when there is a chance.
- Early CBT-I trials are encouraging but population-specific. Eligibility, intervention, comparator, and follow-up differ across studies.
- Do not turn a symptom result into a promise about parent or infant outcomes. Depression, infant sleep, and longer-term benefit need their own evidence.
- Use clinical support for treatment and safety decisions. Pregnancy, postpartum recovery, caregiving, and medication considerations call for individualized care.
Related Topics
- Manber R, Bei B, Suh S, et al., “Randomized Controlled Trial of Cognitive Behavioral Therapy for Perinatal Insomnia: Postpartum Outcomes,” Journal of Clinical Sleep Medicine (2023). PubMed
- Quin N, et al., “Preventing Postpartum Insomnia: Findings from a Three-Arm Randomized-Controlled Trial of Cognitive Behavioral Therapy for Insomnia, a Responsive Bassinet, and Sleep Hygiene,” Sleep (2024). PubMed
- Manber R, Bei B, Simpson N, et al., “Cognitive Behavioral Therapy for Prenatal Insomnia: A Randomized Controlled Trial,” Obstetrics & Gynecology (2019). PubMed
- American College of Obstetricians and Gynecologists, “Perinatal Mental Health Conditions” (patient information). ACOG
- U.S. Food and Drug Administration, “FDA Adds Boxed Warning for Risk of Serious Injuries Caused by Sleepwalking with Certain Prescription Insomnia Medicines” (2019). FDA safety communication